Page 17 - Sanket Koul

India logs 2,710 active Covid-19 cases, Kerala tops with 1,147 infections

Health ministry data suggests the country saw 168% rise in active Covid cases in the last four days

CDSCO lists 17 drugs safe to flush to prevent harm from misuse at home

Regulator's draft guidance allows flushing of 17 high-risk drugs including opioids; calls for drug take-back sites to curb AMR, environmental and public health risks

Centre to aid development of indigenous thrombectomy device for stroke

Technology Development Board to fund S3V Vascular Technologies for manufacturing India's first thrombectomy device, aiming to reduce import dependency and boost stroke care

Whiteland Corp launches Marriott's first branded residence in Gurugram

Planned investment of ₹5,600 crore and projected topline of ₹15,000 crore, the development will include 1,700 Westin-branded residences with no hotel component

Need to create capacity at secondary, higher secondary levels: Secy

School Education Secretary Sanjay Kumar calls for more secondary and higher secondary schools to address dropout rates and align with NEP 2020 enrolment targets

Trump effect: Visa hurdles, scrutiny may defer Indian students' US dream

The proposed social-media scrutiny and suspension of student visa interviews could lead to delays in the application process for Indian students

India crosses 1,000 active Covid-19 cases, Kerala tops with 430 infections

The country clocked 752 new Covid-19 infections between May 19 and 26, seven deaths reported during the period

University of Liverpool to open Bengaluru campus, start by August 2026

The institute becomes the second UK university after Southampton to get UGC approval; 15 foreign varsities to open India campuses this academic year, says Pradhan

Donald Trump-Harvard battle: American Dream of Indian students at risk

Harvard currently hosts around 10,158 international students and scholars across its schools. Of these, 788 -- the second-largest cohort after China -- are from India, according to university data

From Kerala to Uttar Pradesh, states step up vigil as Covid returns

Masks, tests and advisories return as states like Kerala, UP and Odisha increase vigilance amid rising Covid-19 cases driven by new Omicron sub-variants

Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise

Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance

IHH's move to seek increased damages may not affect Fortis expansion plans

Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles

Mankind Pharma Q4: Profit drops 10%, revenue up 27% on domestic growth

Strong chronic therapy performance, BSV consolidation drive revenue growth in Q4; net profit declines 10 per cent year-on-year to Rs 425 crore

Hypertension, anti allergy meds among 196 drugs flagged by CDSCO as NSQ

Monthly CDSCO alert identifies 196 batches of drugs as not of standard quality and flags one Deca-Durabolin injection as spurious and under investigation

Fortis Healthcare Q4 profit drops 7% on rise in quarterly expenses

The hospital chain's revenue rose 12.4% to Rs 2,007 crore in Q4 FY25 driven by hospital and diagnostics segments, but higher expenses and impairments hit net profit

India logs 164 new Covid-19 cases in one week, active cases cross 250

India records 164 new Covid-19 cases between May 12 and 19, with Kerala, Tamil Nadu and Maharashtra reporting most cases; officials say symptoms remain mild

IHH subsidiary seeks Rs 11,800 cr damages from Daiichi over Fortis deal

IHH arm NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore, alleging obstruction of Fortis Healthcare acquisition via stalled open offer

DLF records highest-ever sales in FY25 on super luxury housing boom

Projects like The Dahlias and Privana West fuelled DLF's FY25 sales to a record Rs 21,223 crore, with strong demand from domestic buyers and NRIs

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%

Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities

Bhutani Infra, Yashoda Hospitals in ₹1,000 cr JV for Noida project

Fully AI-integrated project in Greater Noida